Maynard Um
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 77c
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Misses Q1 EPS by 45c
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Regains Nasdaq Compliance
-
-
-
-
-
443,996 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

